Product Categories
| Country: | China |
|---|---|
| Tel: | 0531-88723173 |
| Mobile: | 18596073690 |
| E-mail: | 1047208234@qq.com |
| QQ: | 1047208234 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Landiolol Impurity 2 HCl | Details |
| 3,5-Dibromo-2-methylaminobenzyl alcohol | Details |
| N-nitrosoamine bromoxaz impurity | Details |
| 1-(3-Chloro-5-{[4-(4-chloro-5-bromothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]carbamoyl}pyridin-2-yl)piperidine-4-carboxylic acid ethyl ester (AFQBP-IM-310) | Details |
| Atracurium Besylate EP Impurity O (Cis-Atracurium) | Details |
| Tenapanor Impurity 24 | Details |
| Benidipine hydrochloride SM2-4 | C12H11NO | 76509-17-6 | Details |
| 10,11-Dibromo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide | C15H12Br2N2O | 59690-99-2 | Details |
| Impurity 3 of neostigmine methylsulfate | C10H17NO5S | 4312-54-3 | Details |
| Fmoc-D-2-Nal-D-2-Nal-OH | Details |
| 3,4-Dimethoxyphenylacetamide | C10H13NO3 | 5663-56-9 | Details |
| D-Lactic Acid Sodium Salt | C3H7NaO3 | 920-49-0 | Details |
| Ethyl 2-(1H-imidazol-1-yl)acetate | C7H10N2O2 | 17450-34-9 | Details |
| Mitoxantrone EP Impurity D | C22H26N4O6 | 137132-70-8 | Details |
| Impurity I of Aztreonam Avibactam Sodium for Injection | Details |
| Acrylate Quaternary Ammonium Benzenesulfonic Acid Impurity F | Details |
| 2-[[[(5-Methoxy-1H-benzimidazol-2-yl)thiosulfonyl]methyl]-3,5-dimethyl-4(1H)-pyridone | Details |
| Fluralaner | C22H17Cl2F6N3O3 | 864731-61-3 | Details |
| Methyl 4-phenylbutanoate | C11H14O2 | 2046-17-5 | Details |
| Atracurium Intermediate I | C27H37NO6 | 1075726-70-3 | Details |
| Barbituric Acid Impurity HC1433-317 | C33H35N5O5 | 2380229-45-6 | Details |
| Methyl 3-bromo-2-(methylamino)benzoate | C9H10BrNO2 | 1945956-02-4 | Details |
| C8H19O4P | 70069-20-4 | Details |
| (R)-10-Cyclopropyl-1-(9H-fluoren-9-yl)-3,6-dioxo-2,9-dioxa-4,7-diazaundecane-11-carboxylic acid benzyl ester | C30H30N2O6 | 2414393-49-8 | Details |
| N-Nitroso-propylamineocaine | Details |
| Randilol hydrochloride impurity 5 (Sodium salt) | Details |
| Atracurium Impurity 7 (Atrac D-isomer) | Details |
| N-Nitroso-deethyl Lidocaine | Details |
| Acrylate Quaternary Ammonium Benzenesulfonic Acid EP Impurity E | Details |
| 5-Benzyl-3,6-dioxo-2-piperazineacetic acid | C13H14N2O4 | ‘5262-10-2 | Details |
| (R)-Cyclopropyl-hydroxy-acetic acid | C5H8O3 | 134624-47-8 | Details |
| methyl 3-aminocrotonate | C5H9NO2 | 21731-17-9 | Details |
| Dehydro Nicardipine HCl Impurity 2 | C15H15NO5 | 2469735-68-8 | Details |
| Atracurium Besylate Impurity A - Cis | Details |
| Oxalic acid | C2H2O4 | 68603-87-2 | Details |
| Salicylaldehyde azine | C14H12N2O2 | 959-36-4 | Details |
| 5-bromo-4-(4-chlorothiophen-2-yl)thiazol-2-amine | C7H4BrClN2S2 | 2161380-87-4 | Details |
| Cefotaxime Impurity N | C14H15N5O6S2 | Details |
| Cenobamate Impurity 28 | C12H10ClNO3 | 1208525-34-1 | Details |
| 1-ethyl-piperidine-4-carboxylic acid ethyl ester | C10H19NO2 | 24252-38-8 | Details |
| 1-(3-Chloro-5-{[4-(Thiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]carbamoyl}pyridin-2-yl)piperidine-4-carboxylic acid ethyl ester (AFQBP-IM-309) | Details |
| Nidatinib HC1433-3115 Impurity XIV | Details |
| Tenapanor Impurity 22 | Details |
| 5-Methoxy-2-[[((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)thio]methyl]-1-methylbenzimidazole and 6-methoxy-2-[[((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)thio]methyl]-1-methylbenzimidazole | Details |
| 5-Methoxy-2-[[(3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole | Details |
| Tris(2-Chloroethyl)Amine Hydrochloride | C6H13Cl4N | 817-09-4 | Details |
| Progesterone EP Impurity B | C21H32O2 | 145-14-2 | Details |
| 5,6-Dichloronicotinic acid ethyl ester | C8H7Cl2NO2 | 401566-69-6 | Details |
| 2-Hydroxy-2-(pyridin-3-yl)acetonitrile | C7H6N2O | 17604-74-9 | Details |
| Fmoc-β-Ala-D-3-Pal-OH | Details |
| Olaparib Impurity SM3-11 | C10H18N2O | 547698-14-6 | Details |
| Landiolol Impurity 1 HCl | Details |
| Intermediate 2 high-temperature condensation impurity 2 | Details |
| Cefotaxime Sodium Impurity V | Details |
| Impurity G of neostigmine methyl sulfate | Details |
| Tolvaptan | C24H29NO5 | 54088-62-9 | Details |
| Dehydro Aripiprazole | C23H25Cl2N3O2 | 129722-25-4 | Details |
| Fluralaner Impurity A | C20H15Cl2F3N2O4 | 864731-37-3 | Details |
| H-Glu(otbu)-Gly-OH | C11H20N2O5 | Details |
| C18H18N2O4S2 | 61278-80-6 | Details |
| Fluralaner Impurity D | C20H14Cl2F6N2O2 | 864730-61-0 | Details |
| Budesonide Impurity 69 | Details |
| Landiolol Hydrochloride Impurity 4 | Details |
| Barbituric Acid Impurity HC1433-318 | Details |
| Dronedarone Impurity SM1-F (Impurity 5) | C20H19NO5 | 141627-42-1 | Details |
| DG-SM2-ZZD | C15H14BrClO2 | 1280647-32-6 | Details |
| Enalapril EP Impurity E Maleate | C26H32N2O5 | Details |
| Ethyl piperidine-2-carboxylate | C8H15NO2 | 15862-72-3 | Details |
| (9H-fluoren-9-yl)methyl N-(carbamoylmethyl)carbamate | C17H16N2O3 | 115057-37-9 | Details |
| Landiolol Impurity 3 HCl | C25H40ClN3O8 | Details |
| 3'-O-Angeloylhamaudol | C20H22O6 | 84272-84-4 | Details |
| Bumetanide Impurity INT1-I | C14H12N2O7S | 1431505-25-7 | Details |
| Nidatinib HC1433-3114 Impurity XIII | Details |
| 1-(3-Chloro-5-{[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]carbamoyl}pyridin-2-yl)piperidine-4-carboxylic acid (711-I4) | C29H34Cl2N6O3S2 | 570406-98-3 | Details |
| Glycerolphenylbutyrate | C33H38O6 | 611168-24-2 | Details |
| C9H16N2O5 | 7150-63-2 | Details |
| (R)-Zanubrutinib | C27H29N5O3 | 1691249-44-1 | Details |
| Nilotinib EP Impurity F | C29H24F3N7O | 2119583-24-1 | Details |
| 3,5-Dibromo-2-methylamino-benzoic acid methyl ester | C9H9Br2NO2 | 1049106-45-7 | Details |
| Fmoc-β-Ala-D-2-Nal-OH | Details |
| 6-Hydroxynicotinic acid ethyl ester | C8H9NO3 | 18617-50-0 | Details |
| 3-(3-Bromo-4-fluorobenzylidene)isobenzofuran-1(3H)-one | C15H8BrFO2 | 1423030-14-1 | Details |
| Glimepiride EP Impurity H (Glimepiride Toluene Analog) | C24H28N4O5S | 2724503-28-8 | Details |
| Flunixin Meglumine Impurity 9 | C7H15NO6 | 24758-59-6 | Details |
| 2-Hydroxyemodin | C15H10O6 | 641-90-7 | Details |
| 1-(3-Chloro-5-{$[4-(Thiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]carbamoyl$}pyridin-2-yl)piperidine-4-carboxylic acid (AFQBP-IM-E) | Details |
| 1-(3-chloro-5-{[4-(4-chlorothiophen-2-yl)-1,3-thiazol-2-yl]carbamoyl}pyridin-2-yl)piperidine-4-carboxylic acid (AFQBP-IM-408) | Details |
| (S)-2-((6-Amino-3-chloro-2-methylphenyl)carbamoyl)-2-methylpyrrolidine-1-carboxylic acid tert-butyl ester | Details |
| Tenapanor Impurity 21 | Details |
| N-(2-Acetylphenyl)-2-chloroacetamide | C10H10ClNO2 | 6140-11-0 | Details |
| Pimavanserin Impurity | C25H34FN3O2 | Details |
| 3,5-Dibromo-2-(dimethylamino)benzoic acid methyl ester | C10H11Br2NO2 | 146273-81-6 | Details |
| pachypodol | C18H16O7 | 33708-72-4 | Details |
| 1-(3-chloro-5-{[4-(4,5-dichlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]carbamoyl}pyridin-2-yl)piperidine-4-carboxylic acid ethyl ester(AFQBP-IM-D) | Details |
| Atracurium Besylate Impurity A - Trans | Details |
| Atracurium EP Impurity N (Atracurium C-epimer) | Details |
| Nidatinib HC1433-3118 Impurity XVII | Details |
| N-(4-fluorophenyl)methyl-N-[[4-(2-methylpropoxy)phenyl]methyl]urea | Details |
| Fmoc-β-Ala-Cys(Trt)-OH | Details |
| Hydroxocobalamin hydrochloride | C62H89ClCoN13O15P | 59461-30-2 | Details |
| Product Total： Product Page： | ||||
| 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 | ||||